3-n-methylspiperone has been researched along with levodopa in 7 studies
Studies (3-n-methylspiperone) | Trials (3-n-methylspiperone) | Recent Studies (post-2010) (3-n-methylspiperone) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
---|---|---|---|---|---|
155 | 6 | 7 | 17,774 | 1,900 | 4,946 |
Protein | Taxonomy | 3-n-methylspiperone (IC50) | levodopa (IC50) |
---|---|---|---|
integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inoue, O; Itoh, T; Långström, B; Suhara, T; Tohgi, H; Tsukada, H; Yamasaki, T; Yonezawa, H | 1 |
Långström, B | 1 |
Frackowiak, RS; Leenders, KL; Marsden, CD; Quinn, N | 1 |
Anderson, JL | 1 |
Bjurling, P; Fasth, KJ; Hartvig, P; Långström, B; Tedroff, J; Torstenson, R; Watanabe, Y | 1 |
Haida, M; Kozuma, R; Shinohara, Y; Takagi, S; Takahashi, W; Yoshii, F | 1 |
Hideyama, T; Kwak, S; Momose, T; Shimizu, J; Tsuji, S | 1 |
1 review(s) available for 3-n-methylspiperone and levodopa
Article | Year |
---|---|
Design of molecules labeled with beta+ emitters for use in multitracer investigations using positron emission tomography.
Topics: Beta Particles; Humans; Isotope Labeling; Levodopa; Methionine; Neurotransmitter Agents; Nomifensine; Raclopride; Salicylamides; Spiperone; Tomography, Emission-Computed | 1990 |
6 other study(ies) available for 3-n-methylspiperone and levodopa
Article | Year |
---|---|
Effect of L-dopa and reserpine on in vivo binding of (3H)-SCH 23390 and (3H)-N-methylspiperone.
Topics: Animals; Benzazepines; Dopamine Agents; Levodopa; Male; Mice; Reserpine; Spiperone; Tritium | 1991 |
Brain dopaminergic system studied in patients with dystonia using positron emission tomography.
Topics: Adult; Brain; Dopamine; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Spiperone; Tomography, Emission-Computed; Torticollis | 1988 |
A rapid and accurate method to realign PET scans utilizing image edge information.
Topics: Acetates; Animals; Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Dopamine Antagonists; Heart; Humans; Image Processing, Computer-Assisted; Levodopa; Oxygen Radioisotopes; Spiperone; Swine; Tomography, Emission-Computed; Water | 1995 |
Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography.
Topics: Amphetamine; Animals; Brain; Cerebrovascular Circulation; Decarboxylation; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Female; Levodopa; Macaca mulatta; Raclopride; Salicylamides; Spiperone; Tomography, Emission-Computed | 1997 |
Magnetic resonance imaging and 11C-N-methylspiperone/positron emission tomography studies in a patient with the interval form of carbon monoxide poisoning.
Topics: Basal Ganglia; Bromocriptine; Carbon Monoxide Poisoning; Carbon Radioisotopes; Caudate Nucleus; Cerebral Hemorrhage; Combined Modality Therapy; Convalescence; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Globus Pallidus; Humans; Hyperbaric Oxygenation; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Nerve Tissue Proteins; Parkinson Disease, Secondary; Psychomotor Performance; Putamen; Receptors, Dopamine D2; Spiperone; Tomography, Emission-Computed | 1998 |
A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis.
Topics: Aged; Amyotrophic Lateral Sclerosis; Cerebrovascular Circulation; Female; Humans; Levodopa; Male; Middle Aged; Motor Neuron Disease; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Spiperone; Substantia Nigra; Tomography, Emission-Computed, Single-Photon | 2006 |